Product Information

TAMSULOSIN HCL 0.4 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0476 per EA under NDC 68382013216. Its NADAC has been published 76 times since Jun 11, 2025.

FDA first approved this application on Apr 27, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TAMSULOSIN HCL 0.4 MG CAPSULE

Tamsulosin Hydrochloride
$0.0476per EA

Strength

.4 mg/1

NDC

68382013216

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TAMSULOSIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078225

FDA Approved

4/27/2010

TE Code

AB

On Market Since

4/27/2010

Pharmacological Classes

Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker

Price Statistics

The NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has been published 76 times since Jun 11, 2025, and over the history we have for it it has declined 13.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0476 per EA
All-time high$0.0567 (Jul 16, 2025)
All-time low$0.0476 (Nov 18, 2026)
52-week high$0.0522
52-week low$0.0476
Median price$0.0509
Average price$0.0515
Largest weekly change-5.1% (Sep 17, 2025)
Weeks tracked76
Tracking sinceJun 11, 2025

Price History

1W

-2.8%

1M

-2.8%

3M

-6.6%

6M

-3.7%

1Y

-5.8%

3Y

N/A

5Y

N/A

All

-13.6%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TAMSULOSIN HCL 0.4 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TAMSULOSIN HCL 0.4 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0476 per EA (NDC 68382013216), effective Nov 18, 2026.

How has the price of TAMSULOSIN HCL 0.4 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has declined 13.6%. It has been tracked across 76 weekly CMS publications since Jun 11, 2025.

What are the highest and lowest recorded NADAC prices for TAMSULOSIN HCL 0.4 MG CAPSULE?

Since Jun 11, 2025, the NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has ranged from a low of $0.0476 (Nov 18, 2026) to a high of $0.0567 (Jul 16, 2025), with a median of $0.0509 per EA.

Are there cheaper alternatives to TAMSULOSIN HCL 0.4 MG CAPSULE?

12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TAMSULOSIN HCL 0.4 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TAMSULOSIN HCL 0.4 MG CAPSULE?

TAMSULOSIN HCL 0.4 MG CAPSULE (NDC 68382013216) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.